10:34 AM ET
10-Q
Financial Results
Autonomix Medical Q2 2026 Results: Net Loss of $3.13M, Loss Narrows
Autonomix Medical, Inc. reported a net loss of $5.85 million for the six months ended September 30, 2026, an improvement from the $10.79 million loss in the prior year period. The company strengthened its balance sheet through warrant exercises, ending the period with $7.69 million in cash and cash equivalents while continuing to develop its proprietary catheter-based sensing and RF ablation technologies.
- Key figure
- Net loss $3.13M